Acticor Makes Case For First-In-Class Heart Drug Glencozimab

French Biotech Initiates Phase II/III Trials

Human heart with blood vessels
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Cardiovascular

More from Therapy Areas